Short rare hTERT-VNTR2-2nd alleles are associated with prostate cancer susceptibility and influence gene expression

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Yoon, Se Lyun ^a   Jung, Se Il ^a   Do, Eun Ju ^a   Lee, Se Ra ^a   Lee, Sang Yeop ^a,b   Chu, In Sun ^b   Kim, Wun Jae ^c   Jung, Jaeil ^d   Kim, Choung S ^e   Cheon, Sang Hyeon ^e   Leem, Sun Hee ^a  

^a Dong A University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Inje University College of Medicine   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LUCIFERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE; TERT PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; ENHANCER REGION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MALE; PROMOTER REGION; PROSTATE CANCER; REPORTER GENE; VARIABLE NUMBER OF TANDEM REPEAT; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSTATE TUMOR;

AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUCIFERASES; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; TELOMERASE;

EID: 77954869983     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-393     Document Type: Article

References (36)

1. Chiu CP, Harley CB. Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc Soc Exp Biol Med 1997, 214(2):99-106.
2. Shay JW, Wright WE. Mutant dyskerin ends relationship with telomerase. Science 1999, 286(5448):2284-2285. 10.1126/science.286.5448.2284, 10636790.
3. Yoshida R, Kiyozuka Y, Ichiyoshi H, Senzaki H, Takada H, Hioki K, Tsubura A. Change in telomerase activity during human colorectal carcinogenesis. Anticancer Res 1999, 19(3B):2167-2172.
4. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266(5193):2011-2015. 10.1126/science.7605428, 7605428.
5. Cerni C. Telomeres, telomerase, and myc. An update. Mutat Res 2000, 462(1):31-47. 10.1016/S1383-5742(99)00091-5, 10648922.
6. Leem SH, Londoño-Vallejo JA, Kim JH, Bui H, Tubacher E, Solomon G, Park JE, Horikawa I, Kouprina N, Barrett JC, Larionov V. The human telomerase gene: complete genomic sequence and analysis of tandem repeat polymorphisms in intronic regions. Oncogene 2002, 21(5):769-777. 10.1038/sj.onc.1205122, 11850805.
7. Szutorisz H, Palmqvist R, Roos G, Stenling R, Schorderet DF, Reddel R, Lingner J, Nabholz M. Rearrangements of minisatellites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas. Oncogene 2001, 20(20):2600-2605. 10.1038/sj.onc.1204346, 11420670.
8. Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med 1993, 329(8):517-523. 10.1056/NEJM199308193290801, 8336750.
9. Bennett ST, Lucassen AM, Gough SCL, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Rønningen KS, Barnett AH, Bain SC, Todd JA. Susceptibility to human type I diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995, 9(3):284-292. 10.1038/ng0395-284, 7773291.
10. Jeong YH, Kim MC, Ahn EK, Seol SY, Do EJ, Choi HJ, Chu IS, Kim WJ, Kim WJ, Sunwoo Y, Leem SH. Rare exonic minisatellite alleles in MUC2 influence susceptibility to gastric carcinoma. PLoS ONE 2007, 2(11):e1163. 10.1371/journal.pone.0001163, 2065792, 18000536.
11. Seol SY, Lee SY, Kim YD, Do EJ, Kwon JA, Kim SI, Chu IS, Leem SH. Minisatellite polymorphisms of the SLC6A19: susceptibility in hypertension. Biochem Biophys Res Commun 2008, 374(4):714-719. 10.1016/j.bbrc.2008.07.094, 18671945.
12. Paquette J, Giannoukakis N, Polychronakos C, Vafiadis P, Deal C. The INS 5' variable number of tandem repeats is associated with IGF2 expression in humans. J Biol Chem 1998, 273(23):14158-14164. 10.1074/jbc.273.23.14158, 9603916.
13. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001, 1(2):152-156.
14. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R. Direct activation of TERT transcription by c-MYC. Nat Genet 1999, 21(2):220-224. 10.1038/6010, 9988278.
15. Horikawa I, Cable PL, Mazur SJ, Appella E, Afshari CA, Barrett JC. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression. Mol Biol Cell 2002, 13(8):2585-2597. 10.1091/mbc.E01-11-0107, 117927, 12181331.
16. Chakravarti A, Lynn A. Meiotic mapping in human. Genome analysis: A laboratory manual 1999, 1-69. New York: Cold Spring Harbor Laboratory Press, Birren B, Green ED, Klapholz S, Myers RM, Roskams.
17. Song C, Kang T, Ro JY, Lee MS, Kim CS, Ahn H. Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men. J Korean Med Sci 2005, 20(2):262-266. 10.3346/jkms.2005.20.2.262, 2808603, 15831998.
18. Kang T, Song C, Song GH, Shin GH, Shin DI, Kim CS, Ahn H. The anatomic distribution and pathological characteristics of prostate cancer: A mapping analysis. Korean J Urol 2006, 47(6):578-585.
19. Lee YJ, Kim DI, Lee HE, Won JK, Hong EK, Lee GK, Lee KH, Park WS. Pathologic features of Korean prostate adenocarcinoma: Mapping analysis of 83 cases. The Korean Journal of Pathology 2006, 40(3):204-209.
20. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. Prostate specific antigen best practice statement: 2009 update. J Urol 2009, 182(5):2232-2241. 10.1016/j.juro.2009.07.093, 19781717.
21. Sinecen M, Makinaci M. Classification of prostate cell nuclei using artificial neural network methods. Engineering and Technology 2005, 7:170-172.
22. Meigs JB, Dupuis J, Herbert AG, Liu C, Wilson PW, Cupples LA. The insulin gene variable number tandem repeat and risk of type 2 diabetes in a population-based sample of families and unrelated men and women. J Clin Endocrinol Metab 2005, 90(2):1137-1143. 10.1210/jc.2004-1212, 15562019.
23. Wang Y, Hu Z, Liang J, Wang Z, Tang J, Wang S, Wang X, Qin J, Wang X, Shen H. A tandem repeat of human telomerase reverse transcriptase (hTERT) and risk of breast cancer development and metastasis in Chinese women. Carcinogenesis 2008, 29(6):1197-1201. 10.1093/carcin/bgn099, 18413362.
24. Rosell R, Calvo R, Sánchez JJ, Maurel J, Guillot M, Monzó M, Núñez L, Barnadas A. Genetic susceptibility associated with rare HRAS1 varaiable number of tandem repeats alleles in Spanish non-small cell lung cancer patients. Clin Cancer Res 1999, 5(7):1849-1854.
25. Weitzel JN, Ding S, Larson GP, Nelson RA, Goodman A, Grendys EC, Ball HG, Krontiris TG. The HRAS1 minisatellite locus and risk of ovalian cancer. Cancer res 2000, 60(2):259-61.
26. Green M, Krontiris TG. Allelic variation of reporter gene activation by the HRAS1 minisatellite. Genomics 1993, 17(2):429-434. 10.1006/geno.1993.1343, 8406494.
27. Turri MG, Cuin KA, Porter AC. Characterisation of a novel minisatellite that provides multiple splice donor sites in an interferon-induced transcript. Nucleic Acids Res 1995, 23(11):1854-1861. 10.1093/nar/23.11.1854, 306954, 7596809.
28. Ahn EK, Kim WJ, Kwon JA, Choi PJ, Kim WJ, Sunwoo Y, Heo J, Leem S. Variants of MUC5B minisatellites and the susceptibility of bladder cancer. DNA Cell Biol 2009, 28(4):169-176. 10.1089/dna.2008.0827, 19191526.
29. Colgin LM, Reddel RR. Telomere maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev 1999, 9(1):97-103. 10.1016/S0959-437X(99)80014-8, 10072358.
30. Horikawa I, Barrett JC. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003, 24(7):1167-1176. 10.1093/carcin/bgg085, 12807729.
31. Meyerson M. Role of telomerase in normal and cancer cells. J Clin Oncol 2000, 18(13):2626-2634.
32. Shah J, Khaksar SJ, Sooriakumara P. Management of prostate cancer. Part 3: metastatic disease. Expert Rev Anticancer Ther 2006, 6(5):813-821. 10.1586/14737140.6.5.813, 16759171.
33. Onda M, Li D, Suzuki S, Nakamura I, Takenoshita S, Brogren CH, Stampanoni S, Rampino N. Expansion of microsatellite in the thyroid hormone receptor-alpha1 gene linked to increased receptor expression and less aggressive thyroid cancer. Clin Cancer Res 2002, 8(9):2870-2874.
34. Suh J, Rabson AB. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?. J Cell Biochem 2004, 91(1):100-117. 10.1002/jcb.10729, 14689584.
35. Ye Q, Chung LW, Li S, Zhau HE. Identification of a novel FAS/ER-alpha fusion transcript expressed in human cancer cells. Biochim Biophys Acta 2000, 1493(3):373-377.
36. Brandt B, Meyer-Staeckling S, Schmidt H, Agelopoulos K, Buerger H. Mechanisms of egfr Gene Transcription Modulation: Relationship to Cancer Risk and Therapy Response. Clin Cancer Res 2006, 12(24):7252-7260. 10.1158/1078-0432.CCR-06-0626, 17189396.